Castle Biosciences (CSTL) EBIT Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -31.42% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 6.03% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -3.96% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 8.95% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 12.23% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 1.37% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 2.95% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 73.97% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -3.05% |
| 10 | Castle Biosciences | 738.56 Mn | 476.84 Mn | 63.15 Mn | 16.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.42% |
| Dec 31, 2025 | 44.86% |
| Sep 30, 2025 | 31.89% |
| Jun 30, 2025 | -2.30% |
| Mar 31, 2025 | -4.44% |
| Dec 31, 2024 | 31.37% |
| Sep 30, 2024 | 34.44% |
| Jun 30, 2024 | 36.96% |
| Mar 31, 2024 | -8.49% |
| Dec 31, 2023 | -23.12% |
| Sep 30, 2023 | -35.20% |
| Jun 30, 2023 | -220.11% |
| Mar 31, 2023 | -218.88% |
| Dec 31, 2022 | -120.62% |
| Sep 30, 2022 | -90.03% |
| Jun 30, 2022 | -104.33% |
| Mar 31, 2022 | -323.84% |
| Dec 31, 2021 | -73.05% |
| Sep 30, 2021 | -60.61% |
| Jun 30, 2021 | -48.94% |